As a small charity, we rely on grants and voluntary donations to ensure that we can continue helping the individuals and families in our community. As a result we are forever grateful to our amazing grant providers, who enable us to continue our work supporting those affected by Niemann-Pick disease.
Our grant providers include:
BBC Children in Need:
BBC Children in Need is very important to us here at NPUK; their generous grant funding programme has provided part-funding for our Clinical Nurse Specialist since 1999. This has enabled us to continue providing much-needed support to children and families affected by Niemann-Pick diseases – support that is not available elsewhere and would not exist without the kindness and generosity of all those donating to the BBC Children in Need Appeal each year.
Pictured: Shona Beveridge (17, NP-C), with The One Show’s Matt Baker and Alex Jones – Shona took part in the Rickshaw Challenge 2017 in support of BBC Children in Need.
The Big Lottery Fund:
We are now approaching the end of the second year of our Big Lottery funded project, “Shaping our Future Together”. The aim of this five year project is to improve and implement new support services and resources that will help us more effectively reach those affected by Niemann-Pick and their families.
Pictured: NPUK Project Team Leader Louise Metcalfe (second on the right) at our Annual Family Conference. Louise’s post, as well as NPUK: Project Families Officer Steve Neal, are fully funded by The Big Lottery Fund.
The Hollie Foundation:
NPUK is deeply grateful to The Hollie Foundation for its continued support of our work through grant funding in 2017/2018. The Foundation has generously awarded further grant funding to part support the post of NPUK’s Senior Families Advocate, held by the very dedicated Elizabeth Davenport. This is the fourth consecutive year that The Hollie Foundation has supported this essential post, enabling Elizabeth to provide a high-level of individualised non-clinical support to those affected by all types of Niemann-Pick disease and their families. In addition, The Hollie Foundation has also kindly granted much-needed funding to cover the cost of the Children and Young Persons’ Activity Programme and our Annual Family Conference and our regional family get-togethers.
Pictured: The Hollie Foundation Co-founder and NPUK Trustee Helen Carter (third from the left) represented NPUK at the 5th Biennial “Face to Face” International Niemann-Pick Disease Alliance (INPDA) Meeting 2017.
ALACHUA, FL – (Globe Newswire) – March 14, 2019 – CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, announced today that the company has initiated planning for a Phase I clinical trial for treatment of Alzheimer’s Disease. The trial will use Trappsol® Cyclo™, the company’s proprietary formulation of hydroxypropyl beta cyclodextrin, administered intravenously.Read more
IntraBio Clinical Trial Authorization Application Approved by the MHRA for the Treatment of Niemann-Pick Disease type C (NPC): OXFORD, UK, March 11, 2019-- IntraBio Inc., a late-stage biopharmaceutical company, today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved its Clinical Trial Authorisation (CTA) Application for Clinical Trial IB1001-201 with its lead compound (IB1001) for the treatment of Niemann-Pick disease Type C (NPC).Read more